Efficacy of racemic albuterol versus levalbuterol used as a continuous nebulization for the treatment of acute asthma exacerbations: A randomized, double-blind, clinical trial

Journal of Asthma

Volumn 48, Issue 7, 2011, Pages 752-

  Wilkinson, Matthew ^a   Bulloch, Blake ^b  

^a DELL INC   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; RACEMIC ALBUTEROL; SALBUTAMOL; UNCLASSIFIED DRUG;

ASTHMA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; NEBULIZATION; SCORING SYSTEM; SPIROMETRY;

EID: 80052019441     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.594141     Document Type: Letter

References (0)